biogenesis records

MLB’s civil case against Biogenesis and others is still proceeding. One of the others is interesting.

38 Comments

Part of MLB’s deal with Anthony Bosch is that the league will dismiss the lawsuit it filed against him. It hasn’t done that yet. Which isn’t terribly surprising as MLB is still probably wanting to ensure continued cooperation from him and to ensure that they get something of value from him. The court likely won’t make the league do anything until various deadlines approach that require its attention.

But there are other defendants besides Bosch. One of them is his former colleague who is alleged by MLB to have also given players PEDs. His name is Carlos Acevedo and just this afternoon his latest request to have the lawsuit against him dismissed was denied, so he’s still in MLB’s crosshairs.

Acevedo is an interesting character here. I presume his defense — in addition to some statute of limitations grounds mentioned in the linked article — will be that he had nothing to do with Biogenesis. Which may be technically true. However, Acevedo and Bosch were partners in a predecessor anti-aging clinic before they had a falling out and went their separate ways. And it wasn’t too terribly long ago that this happened. The third partner in that clinic, a guy named Xavier Romero, left with Acevedo. He told the New York Times a couple of months ago that (a) he didn’t do anything with athletes; and (b) Bosch was a wreck and that he was surprised that he’d be able to lure baseball players as clients. The article also noted that Acevedo had a good reputation in the anti-aging community and worked with solid medical companies in the past.

Which makes me wonder about Major League Baseball’s interest in Acevedo. Do they think that he was a source of PEDs to players? If so, you’d think he’d be a better target for cooperation than Bosch, given his apparently more august standing in the world, his greater ability (in Romano’s view, one presumes) to lure high profile clients; and, by extension, his fewer credibility problems. On the other hand, if they don’t think he was involved, this lawsuit, with respect to Acevedo anyway, stinks to high heavens.

While I disagreed with Major League Baseball’s lawsuit when it was filed and still believe it’s the weakest legal sauce imaginable, I don’t think MLB is in the business of harassing truly innocent parties, which is what they’d be doing here if Acevedo didn’t have some sort of involvement in providing drugs to players. Which makes me think that maybe they’re trying to do with Acevedo what they did with Bosch: flip him and get him to talk about players’ drug use. Which suggests that either MLB doesn’t think that it yet has the goods or that it’s being extremely deliberate as it builds its case.

If they do have the goods on the players, though, you’d think they’d quit pursuing Acevedo, right?

Cubs sign Brett Anderson to a $3.5 million deal

Brett Anderson
AP Photo/J Pat Carter
Leave a comment

Ken Rosenthal of FOX Sports reports that the Cubs have signed pitcher Brett Anderson to a contract, pending a physical. Anderson, apparently, impressed the Cubs during a bullpen session held in Arizona recently. According to Jeff Passan of Yahoo Sports, the deal is for $3.5 million, but incentives can bring the total value up to $10 million.

Anderson, 28, has only made a total of 53 starts and 12 relief appearances over the past five seasons due to a litany of injuries. This past season, he made just three starts and one relief appearance, yielding 15 runs on 25 hits and four walks with five strikeouts in 11 1/3 innings. The lefty dealt with back, wrist, and blister issues throughout the year.

When he’s healthy, Anderson is a solid arm to have at the back of a starting rotation or in the bullpen. The defending world champion Cubs aren’t risking much in bringing him on board.

Yordano Ventura’s remaining contract hinges on the results of his toxicology report

DETROIT, MI - SEPTEMBER 24: Yordano Ventura #30 of the Kansas City Royals pitches against the Detroit Tigers during the first inning at Comerica Park on September 24, 2016 in Detroit, Michigan. (Photo by Duane Burleson/Getty Images)
Duane Burleson/Getty Images
2 Comments

Ken Rosenthal of FOX Sports provides an interesting window into how teams handle a player’s contract after he has died in an accident. It was reported on Sunday that Royals pitcher Yordano Ventura died in a car accident in the Dominican Republic. He had three guaranteed years at a combined $19.25 million as well as two $12 million club options with a $1 million buyout each for the 2020-21 seasons.

What happens to that money? Well, that depends on the results of a toxicology report, Rosenthal explains. If it is revealed that Ventura was driving under the influence, payment to his estate can be nullified. The Royals may still choose to pay his estate some money as a gesture of good will, but they would be under no obligation to do so. However, if Ventura’s death was accidental and not caused by his driving under the influence, then his contract remains fully guaranteed and the Royals would have to pay it towards his estate. The Royals would be reimbursed by insurance for an as yet unknown portion of that contract.

The results of the toxicology report won’t be known for another three weeks, according to Royals GM Dayton Moore. Dominican Republic authorities said that there was no alcohol found at the scene.

Ventura’s situation is different than that of Marlins pitcher Jose Fernandez, who died in a boating accident this past September. Fernandez was not under contract beyond 2016. He was also legally drunk and cocaine was found in his system after the accident. Still, it is unclear whether or not Fernandez was driving the boat. As a result, his estate will receive an accidental death payment of $1.05 million as well as $450,000 through the players’ standard benefits package, Rosenthal points out.